Page last updated: 2024-11-05

trihexyphenidyl and Thrombocytopenia

trihexyphenidyl has been researched along with Thrombocytopenia in 2 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Thrombocytopenia: A subnormal level of BLOOD PLATELETS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cocco, GA1
Loudianos, G1
Pes, GM1
Tolu, F1
Lepori, MB1
Barrocu, M1
Sechi, GP1
Storrie, MC1
Scher, M1
McGuire, J1
Bokan, J1

Other Studies

2 other studies available for trihexyphenidyl and Thrombocytopenia

ArticleYear
"Acquired" hepatocerebral degeneration in a patient heterozygote carrier for a novel mutation in ATP7B gene.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Aug-15, Volume: 24, Issue:11

    Topics: Adenosine Triphosphatases; Adult; Amino Acid Substitution; Basal Ganglia; Cation Transport Proteins;

2009
Thrombocytopenia in the absence of leukopenia associated with the use of neuroleptics.
    The Journal of clinical psychiatry, 1978, Volume: 39, Issue:10

    Topics: Adult; Benztropine; Chlorpromazine; Haloperidol; Humans; Male; Perphenazine; Schizophrenia; Thalasse

1978